GlassScriptPhysician profile
Bruce A Buckingham
NPI 1174560247
$59,235.83
in general payments reported to CMS, 2019-2025
13 companies · $61.84 in 2025
The $61.84 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $4,151 · 2021: $12K · 2022: $7,284 · 2023: $9,809 · 2024: $5,309 · 2025: $61.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,125 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,900 · Travel and Lodging: $2,313 · Food and Beverage: $842.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,125.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,900.00 |
| Travel and Lodging | $2,312.72 |
| Food and Beverage | $842.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $26,733.37 | 2021-2024 | Minimed 780g, Minimed 770g |
| Medtronic Minimed, INC. | $16,964.96 | 2019-2020 | |
| Novo Nordisk INC | $5,355.00 | 2021 | |
| Lilly USA, LLC | $2,625.00 | 2021 | |
| Novo Nordisk As | $2,295.00 | 2019 | |
| Tandem Diabetes Care, INC. | $2,085.81 | 2019-2020 | |
| Convatec INC. | $1,600.00 | 2019 | |
| Insulet Corporation | $1,275.00 | 2020 | |
| Abbott Laboratories | $121.43 | 2024 | Freestyle Libre 3 |
| Sequel Med Tech, LLC | $61.84 | 2025 | Twiist |
| Eli Lilly and Company | $54.32 | 2019 | |
| Senseonics, Incorporated | $51.00 | 2019 | |
| Dexcom, INC. | $13.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Buckingham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.